Image Not FoundImage Not Found

Business

Enveda Raises $311 Million, but the Real Test Starts in Phase 2

The Boulder AI-biotech startup closed a $311 million Series E at a reported $2 billion valuation. The practical…

ByByEmily Johnson Sep 26, 2026

Bessemer’s $5.75 Billion Fund Close Expands AI Financing Power, Not Proof of AI Returns

Bessemer Venture Partners has closed $5.75 billion in new capital, split between early-stage and growth investing, in a…

ByByMichael Smith Sep 24, 2026

Ema Raises $77M Series B to Test Whether Enterprise AI Agents Scale Like Software

Ema says its platform already runs HR, IT, and finance workflows at large companies. The new financing matters…

ByByNoah Kim Sep 23, 2026

Snorkel AI’s $350 Million Series E Tests Whether ‘Data 2.0’ Is Durable AI Infrastructure

Snorkel AI’s $350 million financing at a $3.5 billion valuation turns hard training and evaluation data into a…

ByByJuan Martinez Sep 22, 2026
Image Not Found

Tractian’s $130M Series D Values It at $1.4B and Puts Industrial Physical AI to the Test

Tractian’s new funding gives the company more capital to expand its sensor-and-AI maintenance platform across factories and data…

ByByKen Avery Oct 23, 2026

OpenAI acquires Orchestra Bio to extend Rosalind into drug-development operations

OpenAI says it has acquired Orchestra Bio and will fold the startup into Rosalind, pushing beyond scientific reasoning…

ByByMichael Smith Oct 21, 2026